Clinical trials
Phase 3 Gastrointestinal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 5 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Sun Yat-sen University | 3 |
| National Cancer Center Hospital East | 2 |
| Pfizer | 2 |
| Société des Produits Nestlé (SPN) | 2 |
| Amgen | 1 |
| Anthos Therapeutics, Inc. | 1 |
| AstraZeneca | 1 |
| B. Braun Melsungen AG | 1 |
| British Columbia Cancer Agency | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Neoplasms | 31 |
| Colorectal Neoplasms | 10 |
| Digestive System Neoplasms | 9 |
| Intestinal Neoplasms | 8 |
| Digestive System Diseases | 6 |
| Gastrointestinal Diseases | 6 |
| Intestinal Diseases | 5 |
| Neoplasms | 5 |
| Colonic Diseases | 4 |
| Neoplasm Metastasis | 4 |
Trials
Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.